Entities / Company
Daiichi.
supermarket in Obihiro, Hokkaido, Japan
- Reports this week
- 0
- Active events
- 0
- Connections
- 7
What's happening
Gone quiet
No new reports in 90+ days-
Merck and Daiichi began a Phase III study after Merck acquired co-development rights from Daiichi.Some support2 reports1 development inside
-
Merck and Daiichi successfully advanced an ADC through co-development, gaining Breakthrough Therapy designation from the FDA and orphan drug status in Europe.Some support1 report
No events began in the chosen period. Widen it, or reset.
Around Daiichi this week
News at the entities that move Daiichi most-
FDA StructuralDBV Technologies is seeking regulatory acceptance for its product from the FDA.Moves Daiichi
-
AstraZeneca OperationalAstraZeneca developed the drug Ultomiris, supported by the UAE's Emirates Drug Establishment (EDE).Moves Daiichi
Connections
The 3 strongest of 7, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
AstraZeneca Operational
AstraZeneca and Daiichi are engaged in a formal partnership for joint drug development and marketing.
-
Merck Operational
Merck and Daiichi are engaged in a formal co-development partnership for a Phase III clinical study following the acquisition of co-development rights.
-
FDA Structural
FDA's regulatory data requirements dictate whether Daiichi can achieve accelerated product clearance.